IP Library Granted Patent US 7,709,012
Granted Patent B2
US 7,709,012 · App. 10/863,169 · Granted May 4, 2010

Ophthalmic compositions containing a synergistic combination of two polymers

Assignee: Alcon, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,709,012
App. No.
10/863,169
Granted
May 4, 2010
Kind
B2
Abstract

Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of two polymers that have a synergistic effect on viscosity.

Claims (22)

1. An aqueous composition suitable for topical ophthalmic administration comprising a viscosity enhancing amount of combination of two polymers having a synergistic effect on the composition's viscosity and wherein the combination of two polymers is selected from the group consisting of hydroxypropyl methylcellulose and guar gum; a carboxyvinyl polymer and guar gum; hyaluronic acid and hydroxypropyl methylcellulose; and hyaluronic acid and guar gum, provided that if the composition comprises a carboxyvinyl polymer then the composition does not contain sodium chloride or boric acid;

wherein the aqueous composition has a viscosity that is greater than 150% of a sum of viscosities of two solutions, each of the two solutions respectively including only one of the two polymers and wherein the total concentration of the two polymers in the composition ranges from 0.2-2.0% (w/w) and wherein the composition does not gel upon administration to the eye.

2. The composition of claim 1 wherein the combination of two polymers is a combination of a hydroxypropyl methylcellulose and guar gum.

3. The composition of claim 1 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum.

4. The composition of claim 1 wherein the combination of two polymers is a combination of hyaluronic acid and hydroxypropyl methylcellulose.

5. The composition of claim 1 wherein the combination of two polymers is a combination of hyaluronic acid and guar gum.

6. The composition of claim 1 wherein the carboxyvinyl polymer is a polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol, the hydroxypropyl methylcellulose has a number average molecular weight of approximately 86,000 dalton, the guar gum is hydroxypropyl guar.

7. The composition of claim 1 further comprising an ingredient selected from the group consisting of pharmaceutically acceptable buffering agents; preservatives; non-ionic tonicity-adjusting agents; surfactants; solubilizing agents; stabilizing agents; comfort-enhancing agents; emollients; pH-adjusting agents; and lubricants.

8. The composition of claim 1 further comprising an ophthalmic drug.

9. The composition of claim 8 wherein the ophthalmic drug is selected from the group consisting of anti-glaucoma agents; anti-angiogenesis agents; anti-infective agents; non-steroidal and steroidal anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents.

10. A method of alleviating the symptoms of dry eye comprising topically administering to the eye an aqueous composition comprising a viscosity enhancing amount of a combination of two polymers having a synergistic effect on the composition's viscosity and wherein the combination of two polymers is selected from the group consisting of hydroxypropyl methylcellulose and guar gum; a carboxyvinyl polymer and guar gum; hyaluronic acid and hydroxypropyl methylcellulose; and hyaluronic acid and guar gum, provided that if the composition comprises a carboxyvinyl polymer then the composition does not contain sodium chloride or boric acid;

wherein the aqueous composition has a viscosity that is greater than 150% of a sum of viscosities of two solutions, each of the two solutions respectively including only one of the two polymers and wherein the total concentration of the two polymers in the composition ranges from 0.2-2.0% (w/w) and wherein the composition does not gel upon administration to the eye and wherein the composition alleviates symptoms of dry eye exhibited by the eye.

11. The method of claim 10 wherein the combination of two polymers is a combination of a hydroxypropyl methylcellulose and guar gum.

12. The method of claim 10 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum.

13. The method of claim 10 wherein the combination of two polymers is a combination of hyaluronic acid and hydroxypropyl methylcellulose.

14. The method of claim 10 wherein the combination of two polymers is a combination of hyaluronic acid and guar gum.

15. The method of claim 10 wherein the carboxyvinyl polymer is a polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol, the hydroxypropyl methylcellulose has a number average molecular weight of approximately 86,000 dalton, the guar gum is hydroxypropyl guar.

16. The method of claim 10 further comprising an ophthalmic drug.

17. The composition of claim 1 wherein the combination of two polymers is a combination of a hydroxypropyl methylcellulose and guar gum and the composition has a viscosity of at least 32 cps.

18. The composition of claim 1 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum and the composition has a viscosity of at least 1273 cps.

19. The method of claim 10 wherein the combination of two polymers is a combination of a hydroxypropyl methylcellulose and guar gum and the composition has a viscosity of at least 32 cps.

20. The composition of claim 10 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum and the composition has a viscosity of at least 1273 cps.

Assignments (5)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Mar 31, 2021
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 055782/0741 →
MERGER Recorded Mar 30, 2021
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 055772/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2016
From: NOVARTIS AG
To: ALCON RESEARCH, LTD
Reel/Frame 040670/0679 →
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2004
From: CHOWHAN, MASOOD A.; CHEN, HUAGANG
To: ALCON, INC.
Reel/Frame 015448/0762 →
Continuity (2)
Provisional Application 6047825300 · Jun 13, 2003
Related Publication 20040253280A1 · Dec 16, 2004